Geode Capital Management’s The Oncology Institute TOI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
1,279,443
+893,696
| +232% | +$1.83M | ﹤0.01% | 3049 |
|
|
2025
Q1 | $440K | Buy |
385,747
+38,400
| +11% | +$43.8K | ﹤0.01% | 3589 |
|
|
2024
Q4 | $107K | Sell |
347,347
-32,634
| -9% | -$10.1K | ﹤0.01% | 4080 |
|
|
2024
Q3 | $124K | Buy |
379,981
+19,717
| +5% | +$6.45K | ﹤0.01% | 4042 |
|
|
2024
Q2 | $166K | Buy |
360,264
+6,166
| +2% | +$2.84K | ﹤0.01% | 3982 |
|
|
2024
Q1 | $560K | Buy |
354,098
+14,331
| +4% | +$22.6K | ﹤0.01% | 3569 |
|
|
2023
Q4 | $693K | Buy |
339,767
+34,266
| +11% | +$69.9K | ﹤0.01% | 3488 |
|
|
2023
Q3 | $428K | Buy |
305,501
+45,082
| +17% | +$63.1K | ﹤0.01% | 3659 |
|
|
2023
Q2 | $143K | Sell |
260,419
-271,648
| -51% | -$149K | ﹤0.01% | 4195 |
|
|
2023
Q1 | $361K | Buy |
532,067
+2,447
| +0.5% | +$1.66K | ﹤0.01% | 3780 |
|
|
2022
Q4 | $873K | Buy |
529,620
+8,322
| +2% | +$13.7K | ﹤0.01% | 3409 |
|
|
2022
Q3 | $2.41M | Buy |
521,298
+275,907
| +112% | +$1.28M | ﹤0.01% | 3024 |
|
|
2022
Q2 | $1.24M | Buy |
245,391
+164,989
| +205% | +$834K | ﹤0.01% | 3320 |
|
|
2022
Q1 | $573K | Buy |
80,402
+69,255
| +621% | +$494K | ﹤0.01% | 3867 |
|
|
2021
Q4 | $108K | Buy |
+11,147
| New | +$108K | ﹤0.01% | 4704 |
|
|
2021
Q1 | – | Sell |
-10,327
| Closed | -$113K | – | 4466 |
|
|
2020
Q4 | $113K | Sell |
10,327
-39,673
| -79% | -$434K | ﹤0.01% | 4035 |
|
|
2020
Q3 | $491K | Buy |
+50,000
| New | +$491K | ﹤0.01% | 3436 |
|